Validation of an Allergic Rhinitis Control Test in Children

Allergic rhinitis is a common condition that affects adults as well as children and adolescents, often with impaired quality of life. Patients often report a poor level of satisfaction with the effectiveness of their treatment and are always looking for more drug combinations to improve their symptom. Several tools exist for assessing control of allergic rhinitis, but none has been validated in teenagers or in children. A study conducted in 2008, resulted in the validation of a self-administered control test of allergic rhinitis (ARCT) in patients from 12 years of age. We propose to adapt ARCT adult to pediatric population from 5 to 11 years old.

NCT Number	NCT03075917
Lead Sponsor	University Hospital, Montpellier
Conditions	Allergic Rhinitis
Enrollment	137 participants
Start Date	2017-05-04
Primary Completion	2026-07-18 (estimated)
Study Completion	2026-07-18 (estimated)
Updated on ClinicalTrials.gov	2026-07-27